跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLUDEOXYGLUCOSE (F-18) - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FLUDEOXYGLUCOSE (F-18)
Authorized
STANDARD
FLUDEOXYGLUCOSE (F-18)
Lawson Research Institute
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
c4bf839021560d55
Company
Lawson Research Institute
Type
Standard
Approval Details
Approval Id
c4bf839021560d55
Drug Approval Canada Name
FLUDEOXYGLUCOSE (F-18)
Product Name
FLUDEOXYGLUCOSE (F-18)
Status
Marketed
Drug Class
Radiopharmaceutical
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
SCHEDULE C
Ahfs
36:68.00 , 78:00.00
Atc Original
V09IX04 FLUDEOXYGLUCOSE (18F)
Aig Number
0152591014
Company Name
Lawson Research Institute
Company Address
Po Box 5777, Stn B, St.Josephs Hospital, Cp1-109 London Ontario Canada N6A 4V2
Company Detail Path
/organization/lawson-research-institute
Company Information
Pharmaceutical Company Name
Lawson Research Institute
Country Name
Canada
Province Name
Ontario
City Name
london,ontario,country_ca
Address
300-750 Base Line Road East
Website
http://www.lawsonresearch.ca
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
c4bf839021560d55
Type
Standard
Back to Health Canada Approvals